Mice Model Market - Emergence of Crispr, Increasing Demand for Humanized Mice Models and Monoclonal Antibody Production.

The report "Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021", this market is expected to reach USD 1.59 Billion by 2021 from USD 1.11 Billion in 2016, at a CAGR of 7.5%.

Browse 116 market data tables and 46 figures spread through 269 pages and in-depth TOC on “Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021”
http://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html
Early buyers will receive 10% customization on reports.

Industry Insights:

Industry growth is driven by ongoing innovations in mice models, personalized medicine driving the demand for humanized mice models, continuous support in the form of investments and grants, and growing pharmaceutical R&D activities are some of the factors that are expected to drive the growth of the global market in the coming years.

On the other hand, factors like advancements in genetic techniques for the development of genetically modified rats have led to the increased usage of rat models, thereby restraining the market to some extent.

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=1308

Geographical Scenario:

Based on geography, the Mice Mode Market is segmented into the North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period.
North America’s leadership in the market can be attributed to the increased focus on biomedical research in the U.S., rising demands for monoclonal antibody production, nexus between CRO’s and pharmaceutical companies, continued and responsible use of animals ensured by animal care organizations, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada.

Request Sample:
http://www.marketsandmarkets.com/requestsample.asp?id=1308

Industry Leaders:

The prominent players in the Mice Model Market are Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), JANVIER LABS (France), Harbour BioMed (China), TRANS GENIC, Inc. (Japan), genOway (France), and Horizon Discovery Group plc (U.S.)

Market Stakeholders:
• Mice models and services companies
• Mice model and services distributors
• Animal care products manufacturers and suppliers
• Out–licensing life sciences companies (Pharmaceutical/Biopharmaceutical/Biotechnology)
• In–licensing life sciences companies (Pharmaceutical/Biopharmaceutical/Biotechnology)
• Clinical research organizations (CROs)
• Academic institutes
• Government and private research institutes
• Medical research centres
• Public and private animal health agencies
• Animal care associations
• Business consultancies
• Venture capitalists
About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441